{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T04:19:38Z","timestamp":1745554778505,"version":"3.40.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,24]]},"DOI":"10.7759\/cureus.82899","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T12:48:23Z","timestamp":1745498903000},"source":"Crossref","is-referenced-by-count":0,"title":["Effect of UV-A1 Phototherapy Treatment on Scleroderma: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Stephanie","family":"Nagy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lily","family":"Tehrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc M","family":"Kesselman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0889-857x(03)00022-x","article-title":"Scleroderma epidemiology","volume":"29","author":"Mayes MD","year":"2003","unstructured":"Mayes MD. Scleroderma epidemiology. Rheum Dis Clin North Am. 2003, 29:239-54. 10.1016\/s0889-857x(03)00022-x","journal-title":"Rheum Dis Clin North Am"},{"key":"ref2","article-title":"Systemic Sclerosis (Scleroderma)","author":"Adigun R","year":"2025","unstructured":"Adigun R, Goyal A, Hariz A. Systemic Sclerosis (Scleroderma). StatPearls [Internet], StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20152890","article-title":"Localized scleroderma: clinical spectrum and therapeutic update","volume":"90","author":"Careta MF","year":"2015","unstructured":"Careta MF, Romiti R. Localized scleroderma: clinical spectrum and therapeutic update. An Bras Dermatol. 2015, 90:62-73. 10.1590\/abd1806-4841.20152890","journal-title":"An Bras Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02360-3","article-title":"Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis","volume":"22","author":"Raschi E","year":"2020","unstructured":"Raschi E, Privitera D, Bodio C, et al.. Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis. Arthritis Res Ther. 2020, 22:265. 10.1186\/s13075-020-02360-3","journal-title":"Arthritis Res Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.933468","article-title":"Role of B-cell in the pathogenesis of systemic sclerosis","volume":"13","author":"Thoreau B","year":"2022","unstructured":"Thoreau B, Chaigne B, Mouthon L. Role of B-cell in the pathogenesis of systemic sclerosis. Front Immunol. 2022, 13:933468. 10.3389\/fimmu.2022.933468","journal-title":"Front Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-015-0507-3","article-title":"Environmental risk factors of systemic sclerosis","volume":"37","author":"Marie I","year":"2015","unstructured":"Marie I, Gehanno JF. Environmental risk factors of systemic sclerosis. Semin Immunopathol. 2015, 37:463-73. 10.1007\/s00281-015-0507-3","journal-title":"Semin Immunopathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1491508","article-title":"Immunotherapy of systemic sclerosis","volume":"14","author":"Katsiari CG","year":"2018","unstructured":"Katsiari CG, Simopoulou T, Alexiou I, Sakkas LI. Immunotherapy of systemic sclerosis. Hum Vaccin Immunother. 2018, 14:2559-67. 10.1080\/21645515.2018.1491508","journal-title":"Hum Vaccin Immunother"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.096677","article-title":"EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)","volume":"68","author":"Kowal-Bielecka O","year":"2009","unstructured":"Kowal-Bielecka O, Landew\u00e9 R, Avouac J, et al.. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis. 2009, 68:620-8. 10.1136\/ard.2008.096677","journal-title":"Ann Rheum Dis"},{"key":"ref9","article-title":"Glucocorticoids in systemic sclerosis: weighing the benefits and risks - a systematic review","volume":"31","author":"Iudici M","year":"2013","unstructured":"Iudici M, van der Goes MC, Valentini G, Bijlsma JW. Glucocorticoids in systemic sclerosis: weighing the benefits and risks - a systematic review. Clin Exp Rheumatol. 2013, 31:157-65.","journal-title":"Clin Exp Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1295145","article-title":"The realistic positioning of UVA1 phototherapy after 25\u2009years of clinical experience and the availability of new biologics and small molecules: a retrospective clinical study","volume":"10","author":"Calzavara-Pinton P","year":"2023","unstructured":"Calzavara-Pinton P, Bettolini L, Tonon F, Rossi M, Venturini M. The realistic positioning of UVA1 phototherapy after 25\u2009years of clinical experience and the availability of new biologics and small molecules: a retrospective clinical study. Front Med (Lausanne). 2023, 10:1295145. 10.3389\/fmed.2023.1295145","journal-title":"Front Med (Lausanne)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.13646","article-title":"Phototherapy","volume":"16","author":"Singer S","year":"2018","unstructured":"Singer S, Berneburg M. Phototherapy. J Dtsch Dermatol Ges. 2018, 16:1120-9. 10.1111\/ddg.13646","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00474.x","article-title":"UVA1 radiation triggers two different final apoptotic pathways","volume":"112","author":"Godar DE","year":"1999","unstructured":"Godar DE. UVA1 radiation triggers two different final apoptotic pathways. J Invest Dermatol. 1999, 112:3-12. 10.1046\/j.1523-1747.1999.00474.x","journal-title":"J Invest Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2021.03.001","article-title":"Phototherapy","volume":"96","author":"Barros NM","year":"2021","unstructured":"Barros NM, Sbroglio LL, Buffara MO, Baka JL, Pessoa AS, Azulay-Abulafia L. Phototherapy. An Bras Dermatol. 2021, 96:397-407. 10.1016\/j.abd.2021.03.001","journal-title":"An Bras Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.08.102","article-title":"Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies","volume":"90","author":"Davis DM","year":"2024","unstructured":"Davis DM, Drucker AM, Alikhan A, et al.. Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies. J Am Acad Dermatol. 2024, 90:e43-56. 10.1016\/j.jaad.2023.08.102","journal-title":"J Am Acad Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.09.033","article-title":"Guidelines for phototherapy of mycosis fungoides and S\u00e9zary syndrome: a consensus statement of the United States Cutaneous Lymphoma Consortium","volume":"74","author":"Olsen EA","year":"2016","unstructured":"Olsen EA, Hodak E, Anderson T, Carter JB, Henderson M, Cooper K, Lim HW. Guidelines for phototherapy of mycosis fungoides and S\u00e9zary syndrome: a consensus statement of the United States Cutaneous Lymphoma Consortium. J Am Acad Dermatol. 2016, 74:27-58. 10.1016\/j.jaad.2015.09.033","journal-title":"J Am Acad Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12833","article-title":"Efficacy of ultraviolet A1 phototherapy for inflammatory, sclerotic and neoplastic dermatological diseases: a 10-year tertiary referral center experience","volume":"39","author":"Ronen S","year":"2023","unstructured":"Ronen S, Ramot Y, Zlotogorski A, Shreberk-Hassidim R. Efficacy of ultraviolet A1 phototherapy for inflammatory, sclerotic and neoplastic dermatological diseases: a 10-year tertiary referral center experience. Photodermatol Photoimmunol Photomed. 2023, 39:256-62. 10.1111\/phpp.12833","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021, 10:89. 10.1186\/s13643-021-01626-4","journal-title":"Syst Rev"},{"key":"ref18","article-title":"UVA1 for diffuse cutaneous systemic sclerosis in a Fitzpatrick skin type VI patient: outcomes in the modified Rodnan skin score","volume":"42(2)","author":"Ferreira BR","year":"2017","unstructured":"Ferreira BR, Gameiro AR, Brites MM, Oliveira HS, Reis JP. UVA1 for diffuse cutaneous systemic sclerosis in a Fitzpatrick skin type VI patient: outcomes in the modified Rodnan skin score. Acta Reumatol Port. 2017, 42(2):196-7.","journal-title":"Acta Reumatol Port"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2023.11.005","article-title":"Improvement of systemic sclerosis-associated digital ulcers after ultraviolet A1 phototherapy","volume":"44","author":"Olivet MM","year":"2024","unstructured":"Olivet MM, Yang K, Graham LV. Improvement of systemic sclerosis-associated digital ulcers after ultraviolet A1 phototherapy. JAAD Case Rep. 2024, 44:3-5. 10.1016\/j.jdcr.2023.11.005","journal-title":"JAAD Case Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13321","article-title":"A retrospective review of UVA1 treatment: an Australian experience from a single centre","volume":"61","author":"Pitney T","year":"2020","unstructured":"Pitney T, Pitney MJ. A retrospective review of UVA1 treatment: an Australian experience from a single centre. Australas J Dermatol. 2020, 61:318-23. 10.1111\/ajd.13321","journal-title":"Australas J Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04137.x","article-title":"Low-dose UVA\u2081 phototherapy for scleroderma: what benefit can we expect?","volume":"26","author":"Pereira N","year":"2012","unstructured":"Pereira N, Santiago F, Oliveira H, Figueiredo A. Low-dose UVA\u2081 phototherapy for scleroderma: what benefit can we expect?. J Eur Acad Dermatol Venereol. 2012, 26:619-26. 10.1111\/j.1468-3083.2011.04137.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2010.04843.x","article-title":"Effectiveness of medium-dose ultraviolet A1 phototherapy in localized scleroderma","volume":"50","author":"Su O","year":"2011","unstructured":"Su O, Onsun N, Onay HK, Erdemoglu Y, Ozkaya DB, Cebeci F, Somay A. Effectiveness of medium-dose ultraviolet A1 phototherapy in localized scleroderma. Int J Dermatol. 2011, 50:1006-13. 10.1111\/j.1365-4632.2010.04843.x","journal-title":"Int J Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09438.x","article-title":"Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study","volume":"162","author":"Andres C","year":"2010","unstructured":"Andres C, Kollmar A, Mempel M, Hein R, Ring J, Eberlein B. Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study. Br J Dermatol. 2010, 162:445-7. 10.1111\/j.1365-2133.2009.09438.x","journal-title":"Br J Dermatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15368","article-title":"Ultraviolet A1 phototherapy for the treatment of localized scleroderma","volume":"47","author":"Furuhashi T","year":"2020","unstructured":"Furuhashi T, Torii K, Ikumi K, Kato H, Nishida E, Morita A. Ultraviolet A1 phototherapy for the treatment of localized scleroderma. J Dermatol. 2020, 47:792-5. 10.1111\/1346-8138.15368","journal-title":"J Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12185","article-title":"Ultraviolet A1 phototherapy beyond morphea: experience in 83 patients","volume":"31","author":"Connolly KL","year":"2015","unstructured":"Connolly KL, Griffith JL, McEvoy M, Lim HW. Ultraviolet A1 phototherapy beyond morphea: experience in 83 patients. Photodermatol Photoimmunol Photomed. 2015, 31:289-95. 10.1111\/phpp.12185","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2021.113127","article-title":"Concentrations of metalloproteinase-1 in patients with morphea treated with phototherapy: a preliminary study","volume":"39","author":"Malewska-Wo\u017aniak A","year":"2022","unstructured":"Malewska-Wo\u017aniak A, Lodyga M, Adamski Z. Concentrations of metalloproteinase-1 in patients with morphea treated with phototherapy: a preliminary study. Postepy Dermatol Alergol. 2022, 39:972-5. 10.5114\/ada.2021.113127","journal-title":"Postepy Dermatol Alergol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2021.108437","article-title":"Effectiveness of PUVA vs. UVA1 phototherapy in the treatment of morphea patients","volume":"39","author":"Malewska-Wo\u017aniak A","year":"2022","unstructured":"Malewska-Wo\u017aniak A, Osmola-Ma\u00f1kowska A, Adamski Z. Effectiveness of PUVA vs. UVA1 phototherapy in the treatment of morphea patients. Postepy Dermatol Alergol. 2022, 39:757-61. 10.5114\/ada.2021.108437","journal-title":"Postepy Dermatol Alergol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-016-2041-5","article-title":"Fractional carbon dioxide laser versus low-dose UVA-1 phototherapy for treatment of localized scleroderma:\u00a0a clinical and immunohistochemical randomized controlled study","volume":"31","author":"Shalaby SM","year":"2016","unstructured":"Shalaby SM, Bosseila M, Fawzy MM, Abdel Halim DM, Sayed SS, Allam RS. Fractional carbon dioxide laser versus low-dose UVA-1 phototherapy for treatment of localized scleroderma:\u00a0a clinical and immunohistochemical randomized controlled study. Lasers Med Sci. 2016, 31:1707-15. 10.1007\/s10103-016-2041-5","journal-title":"Lasers Med Sci"},{"key":"ref29","unstructured":"Scleroderma. (2023). Accessed. January 20, 2025: https:\/\/www.niams.nih.gov\/health-topics\/scleroderma."},{"key":"ref30","article-title":"Phototherapy","author":"Rathod DG","year":"2025","unstructured":"Rathod DG, Muneer H, Masood S. Phototherapy. StatPearls [Internet], StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-016-0136-3","article-title":"Phototherapy in scleroderma","volume":"6","author":"Hassani J","year":"2016","unstructured":"Hassani J, Feldman SR. Phototherapy in scleroderma. Dermatol Ther (Heidelb). 2016, 6:519-53. 10.1007\/s13555-016-0136-3","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2021.05.007","article-title":"Mechanisms of photosensitivity in autoimmunity","volume":"142","author":"Estadt SN","year":"2022","unstructured":"Estadt SN, Maz MP, Musai J, Kahlenberg JM. Mechanisms of photosensitivity in autoimmunity. J Invest Dermatol. 2022, 142:849-56. 10.1016\/j.jid.2021.05.007","journal-title":"J Invest Dermatol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.11.1063","article-title":"A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma","volume":"54","author":"Kreuter A","year":"2006","unstructured":"Kreuter A, Hyun J, St\u00fccker M, Sommer A, Altmeyer P, Gambichler T. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol. 2006, 54:440-7. 10.1016\/j.jaad.2005.11.1063","journal-title":"J Am Acad Dermatol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(97)80277-0","article-title":"High-dose UVA1 radiation therapy for localized scleroderma","volume":"36","author":"Stege H","year":"1997","unstructured":"Stege H, Berneburg M, Humke S, et al.. High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol. 1997, 36:938-44. 10.1016\/s0190-9622(97)80277-0","journal-title":"J Am Acad Dermatol"},{"key":"ref35","unstructured":"International Radiation Protection Association. (1992). Accessed. January 20, 2025: https:\/\/irpa.net\/members\/OCR_IRPA_8_Proceedings.pdf."},{"key":"ref36","unstructured":"Ultraviolet radiation. (2024). Accessed. January 20, 2025: https:\/\/www.ccohs.ca\/oshanswers\/phys_agents\/ultravioletradiation.html."},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2003.tb00368.x","article-title":"The expression of matrix metalloproteinase-1 mRNA induced by ultraviolet A1 (340-400 nm) is phototherapy relevant to the glutathione (GSH) content in skin fibroblasts of systemic sclerosis","volume":"30","author":"Yin L","year":"2003","unstructured":"Yin L, Yamauchi R, Tsuji T, Krutmann J, Morita A. The expression of matrix metalloproteinase-1 mRNA induced by ultraviolet A1 (340-400 nm) is phototherapy relevant to the glutathione (GSH) content in skin fibroblasts of systemic sclerosis. J Dermatol. 2003, 30:173-80. 10.1111\/j.1346-8138.2003.tb00368.x","journal-title":"J Dermatol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07391.x","article-title":"Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma","volume":"155","author":"Kreuter A","year":"2006","unstructured":"Kreuter A, Hyun J, Skrygan M, Sommer A, Bastian A, Altmeyer P, Gambichler T. Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma. Br J Dermatol. 2006, 155:600-7. 10.1111\/j.1365-2133.2006.07391.x","journal-title":"Br J Dermatol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/BF00373353","article-title":"Effects of tumor necrosis factor-alpha on connective tissue metabolism in normal and scleroderma fibroblast cultures","volume":"284","author":"Takeda K","year":"1993","unstructured":"Takeda K, Hatamochi A, Arakawa M, Ueki H. Effects of tumor necrosis factor-alpha on connective tissue metabolism in normal and scleroderma fibroblast cultures. Arch Dermatol Res. 1993, 284:440-4. 10.1007\/BF00373353","journal-title":"Arch Dermatol Res"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1186\/1471-5945-3-2","article-title":"Altered decorin expression of systemic sclerosis by UVA1 (340-400 nm) phototherapy: immunohistochemical analysis of 3 cases","volume":"3","author":"Sawada H","year":"2003","unstructured":"Sawada H, Isogai Z, Morita A. Altered decorin expression of systemic sclerosis by UVA1 (340-400 nm) phototherapy: immunohistochemical analysis of 3 cases. BMC Dermatol. 2003, 3:2. 10.1186\/1471-5945-3-2","journal-title":"BMC Dermatol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.07802.x","article-title":"Significant downregulation of transforming growth factor-beta signal transducers in human skin following ultraviolet-A1 irradiation","volume":"156","author":"Gambichler T","year":"2007","unstructured":"Gambichler T, Skrygan M, Tomi NS, Breuksch S, Altmeyer P, Kreuter A. Significant downregulation of transforming growth factor-beta signal transducers in human skin following ultraviolet-A1 irradiation. Br J Dermatol. 2007, 156:951-6. 10.1111\/j.1365-2133.2007.07802.x","journal-title":"Br J Dermatol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-004-0513-0","article-title":"Modulation of endothelial dysfunction and apoptosis: UVA1-mediated skin improvement in systemic sclerosis","volume":"296","author":"Breuckmann F","year":"2004","unstructured":"Breuckmann F, Stuecker M, Altmeyer P, Kreuter A. Modulation of endothelial dysfunction and apoptosis: UVA1-mediated skin improvement in systemic sclerosis. Arch Dermatol Res. 2004, 296:235-9. 10.1007\/s00403-004-0513-0","journal-title":"Arch Dermatol Res"},{"key":"ref43","unstructured":"Psoralen plus ultraviolet A photochemotherapy. (2025). Accessed. January 26, 2025: https:\/\/www.uptodate.com\/contents\/psoralen-plus-ultraviolet-a-puva-photochemotherapy."},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2005.00154.x","article-title":"Phototherapy and photochemotherapy of sclerosing skin diseases","volume":"21","author":"Brenner M","year":"2005","unstructured":"Brenner M, Herzinger T, Berking C, Plewig G, Degitz K. Phototherapy and photochemotherapy of sclerosing skin diseases. Photodermatol Photoimmunol Photomed. 2005, 21:157-65. 10.1111\/j.1600-0781.2005.00154.x","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1329414","article-title":"Fractional carbon dioxide laser resurfacing","volume":"26","author":"Ramsdell WM","year":"2012","unstructured":"Ramsdell WM. Fractional carbon dioxide laser resurfacing. Semin Plast Surg. 2012, 26:125-30. 10.1055\/s-0032-1329414","journal-title":"Semin Plast Surg"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19138133","article-title":"Fractional ablative carbon dioxide lasers for the treatment of morphea: a case series and literature review","volume":"19","author":"Klimek P","year":"2022","unstructured":"Klimek P, Placek W, Owczarczyk-Saczonek A. Fractional ablative carbon dioxide lasers for the treatment of morphea: a case series and literature review. Int J Environ Res Public Health. 2022, 19:8133. 10.3390\/ijerph19138133","journal-title":"Int J Environ Res Public Health"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.1998.tb04199.x","article-title":"Carbon dioxide laser resurfacing of peri-oral rhytids in scleroderma patients","volume":"24","author":"Apfelberg DB","year":"1998","unstructured":"Apfelberg DB, Varga J, Greenbaum SS. Carbon dioxide laser resurfacing of peri-oral rhytids in scleroderma patients. Dermatol Surg. 1998, 24:517-9. 10.1111\/j.1524-4725.1998.tb04199.x","journal-title":"Dermatol Surg"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12020657","article-title":"Autoantibodies and clinical correlations in Polish systemic sclerosis patients: a cross-sectional study","volume":"12","author":"\u017bebryk P","year":"2023","unstructured":"\u017bebryk P, Przymusza\u0142a P, Nowak JK, Piorunek T, Mularek-Kubzdela T, Puszczewicz M. Autoantibodies and clinical correlations in Polish systemic sclerosis patients: a cross-sectional study. J Clin Med. 2023, 12:657. 10.3390\/jcm12020657","journal-title":"J Clin Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2024-eular.1670","article-title":"Anti-Ro\/SSA antibodies are predictive of a more severe lung involvement in patients with systemic sclerosis: a study from the heustar database","volume":"83","author":"Burja B","year":"2024","unstructured":"Burja B, Boubaya M, Bruni C, et al.. Anti-Ro\/SSA antibodies are predictive of a more severe lung involvement in patients with systemic sclerosis: a study from the heustar database. Ann Rheum Dis. 2024, 83:1-2. 10.1136\/annrheumdis-2024-eular.1670","journal-title":"Ann Rheum Dis"},{"key":"ref50","article-title":"Anti-SSA\/Ro52 autoantibodies in scleroderma: results of an observational, cross-sectional study","volume":"32","author":"S\u00e1nchez-Montalv\u00e1 A","year":"2014","unstructured":"S\u00e1nchez-Montalv\u00e1 A, Fern\u00e1ndez-Luque A, Sime\u00f3n CP, Fonollosa-Pl\u00e0 V, Mar\u00edn A, Guill\u00e9n A, Vilardell M. Anti-SSA\/Ro52 autoantibodies in scleroderma: results of an observational, cross-sectional study. Clin Exp Rheumatol. 2014, 32:S-177-82.","journal-title":"Clin Exp Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/354292-effect-of-uv-a1-phototherapy-treatment-on-scleroderma-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T12:48:26Z","timestamp":1745498906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/354292-effect-of-uv-a1-phototherapy-treatment-on-scleroderma-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.82899","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,24]]}}}